Back to Barbiturates: The Re-emergence of Phenobarbital in Alcohol Withdrawal Management
Dr. Emily Sarid
Addiction Medicine Fellow, BC Centre on Substance Use
May 14, 2026
12pm – 1pm PT
Learning Objectives:
- Describe the pharmacologic properties of phenobarbital and their clinical relevance in alcohol withdrawal syndrome (AWS)
- Evaluate the emerging evidence comparing phenobarbital and benzodiazepines in the management of AWS, dosing strategies, and clinical considerations.
What’s New in Addiction Medicine? is a lunch-time series featuring clinicians and researchers from BCCSU’s interdisciplinary fellowship program, who will deliver the latest research and information on novel, evidence-based addiction medicine topics.
This free series is geared towards the needs and interests of individuals operating in a healthcare or research setting, however, everyone is welcome and encouraged to attend.
In-person seminar will have complimentary lunch provided.
Register for In-Person Attendance:
Register
Register for Virtual Attendance:
Register
If you have any questions about event logistics, please contact [email protected].